Latest Period
Q2 2026
Security Snapshot
Theriva Biologics, Inc. - Common stock (TOVX) Institutional Ownership
CUSIP: 87164U508
13F Institutional Holders and Ownership History from Q3 2024 to Q2 2026
Institutions Reporting
24
Shares (Excl. Options)
1,980,374
Price
$0.25
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock
- Symbol
- TOVX on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 1,980,374
- Total 13F value
- $495,531
- Portfolio coverage rank
- 0%
- Share change
- +14,662
- Value change
- +$4,553
- Number of holders
- 24
- Shares outstanding
- 9,600,143
- SEC-reported price per share
- $0.22
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- TOVX - Theriva Biologics, Inc. - Common stock is tracked under CUSIP 87164U508.
- 24 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 19 to 24 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $385,351 to $495,531.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 24 institutions filings for Q2 2026.
Security key
87164U508
Latest holder period
Q2 2026
13F holders
24
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
TOVX full holder history
Theriva Biologics, Inc. SEC filings
Theriva Biologics, Inc. company facts
Theriva Biologics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 87164U508:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
TOVX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Jeffrey Matthew Gryga Irrevocable Trust | 7.7% | $300,046 | 739,211 | Jeffrey Matthew Gryga Irrevocable Trust | 24 Oct 2025 | |||
| Empery Asset Management, LP | 5% | -50% | $201,636 | -$179,638 | 504,091 | -47% | Empery Asset Management, LP | 30 Sep 2025 |
| CVI Investments, Inc. | 4.9% | $206,052 | 146,136 | CVI Investments, Inc. | 31 Dec 2024 |
As of 30 Jun 2026, 24 institutional investors reported holding 1,980,374 shares of Theriva Biologics, Inc. - Common stock (TOVX). This represents 21% of the company’s total 9,600,143 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
21%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 5.1% | 486,179 | +153% | 0% | $121,545 |
| JANE STREET GROUP, LLC | 3.5% | 331,922 | +87% | 0% | $83,047 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.1% | 294,021 | -35% | 0% | $73,563 |
| VANGUARD FIDUCIARY TRUST CO | 2.5% | 241,780 | 0% | 0% | $60,445 |
| Ikarian Capital, LLC | 1.2% | 112,076 | 0% | 0% | $28,041 |
| Virtu Financial LLC | 0.91% | 87,138 | -66% | 0% | $22,000 |
| NORTHERN TRUST CORP | 0.86% | 82,700 | 0% | $20,692 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.66% | 63,710 | 0% | $15,940 | |
| UBS Group AG | 0.64% | 61,053 | -73% | 0% | $15,264 |
| XTX Topco Ltd | 0.56% | 53,868 | -43% | 0% | $13,478 |
| Ground Swell Capital, LLC | 0.37% | 35,292 | 0.01% | $8,830 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.29% | 27,646 | 0% | 0% | $6,917 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.25% | 24,064 | 0% | $6,021 | |
| MORGAN STANLEY | 0.21% | 20,299 | -14% | 0% | $5,079 |
| TWO SIGMA SECURITIES, LLC | 0.21% | 19,748 | -81% | 0% | $4,941 |
| TWO SIGMA INVESTMENTS, LP | 0.16% | 15,456 | +0.1% | 0% | $3,867 |
| SCHWARZ DYGOS WHEELER INVESTMENT ADVISORS LLC | 0.16% | 15,000 | 0% | 0% | $3,753 |
| BlackRock, Inc. | 0.08% | 7,504 | 0% | 0% | $1,878 |
| OSAIC HOLDINGS, INC. | 0% | 441 | 0% | 0% | $110 |
| SBI Securities Co., Ltd. | 0% | 358 | +173% | 0% | $90 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 0% | 100 | 0% | $25 | |
| IFP Advisors, Inc | 0% | 11 | 0% | 0% | $3 |
| NFSG Corp | 0% | 5 | 0% | 0% | $1 |
| BARCLAYS PLC | 0% | 3 | 0% | $1 | |
| StoneX Group Inc. | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
8
Latest
Q2 2026
Rows shown
1-8 of 8
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 1,980,374 | $495,531 | +$4,553 | $0.25 | 24 |
| 2026 Q1 | 1,965,271 | $385,351 | +$95,191 | $0.20 | 19 |
| 2025 Q4 | 1,295,504 | $272,379 | +$158,821 | $0.21 | 20 |
| 2025 Q3 | 437,052 | $177,030 | +$57,424 | $0.41 | 18 |
| 2025 Q2 | 291,012 | $126,275 | +$38,331 | $0.43 | 15 |
| 2025 Q1 | 190,681 | $209,751 | +$165,878 | $1.10 | 10 |
| 2024 Q4 | 34,470 | $60,323 | -$627,703 | $1.75 | 9 |
| 2024 Q3 | 491,424 | $677,871 | +$471,525 | $1.38 | 16 |